👋👋Risk of complications in pregnant patients with cardiac implantable electronic devices is now available online! #EPeeps #Cardiology #CardioTwitter https://t.co/Ffx1vpBsTL

Empezando con ilusión el I Curso SEVALBAR de actualización en cardiopatías congénitas, conjuntamente organizado con las unidades de CC de La Fe y Vírgen del Rocío 💙💪🏼

Participa en el Curs i la Jornada SEVALBAR 2024: Actualització en cardiopaties congènites de l'adult i actualització en tetralogia de Fallot. 👩‍⚕️ Dirigits a cardiòlegs, residents i infermeria especialitzada. 📅 27-29 juny 📍 #VallHebron Inscripcions 👇

Certain heart conditions can increase your patients' chance of serious problems for them and their baby. Share this #CardioSmart infographic with your patients that includes tips for getting the conversation started: https://t.co/LmPQPayMsh #ACCCardioOB

Women represent only 23% of participants in HFrEF Trials Showing Improved Mortality (in some studies only 11%!) and it’s not getting better @JACCJournals #JACCAdvances @CardiBeatMD @FaRodriguezMD https://t.co/1DUEizmtxH Time for Change #WIC #AHA2023

In traditionally underrepresented multiracial and multiethnic high‐risk mothers, elevated maternal plasma CysC increased risk of #CVD later in life. #AHAJournals @waikarss @ilori_titi https://t.co/t5843TjIKP